Harnessing the gut microbiota to potentiate the efficacy of CAR T cell therapy Editorial
| Authors: | Gabrielli, G.; Shouval, R.; Ghilardi, G.; Van Den Brink, M.; Ruella, M. |
| Title: | Harnessing the gut microbiota to potentiate the efficacy of CAR T cell therapy |
| Keywords: | treatment outcome; unclassified drug; overall survival; drug efficacy; nonhuman; neurotoxicity; cd8+ t lymphocyte; progression free survival; immune system; carcinogenesis; immunoregulation; immune response; intestine flora; antibody; piperacillin plus tazobactam; tumor microenvironment; meropenem; imipenem; cd19 antibody; human; article; tisagenlecleucel t; chimeric antigen receptor t-cell immunotherapy; axicabtagene ciloleucel; lisocabtagene maraleucel; cell therapy agent; brexucabtagene autoleucel; bcma antibody |
| Journal Title: | HemaSphere |
| Volume: | 7 |
| Issue: | 9 |
| ISSN: | 2572-9241 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2023-09-01 |
| Start Page: | e950 |
| Language: | English |
| DOI: | 10.1097/hs9.0000000000000950 |
| PROVIDER: | scopus |
| PMCID: | PMC10448936 |
| PUBMED: | 37637993 |
| DOI/URL: | |
| Notes: | Source: Scopus |
